Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Population genetic screening programmes: principles, techniques, practices, and policies.

Béatrice Godard1, Leo ten Kate, Gerry Evers-Kiebooms

  • 1INSERM SC11, Paris, France.

European Journal of Human Genetics : EJHG
|January 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical Issues of Risk Management Disclosure in Healthcare Networks.

Healthcare management forum·2026
Same author

Reporting summary results in clinical trial registries: updated guidance from WHO.

The Lancet. Global health·2025
Same author

Experiences of adults living with refractory epilepsy and their views and expectations on receiving results from whole genome sequencing.

Epilepsy research·2023
Same author

Editorial: Prevention, diagnosis and treatment of rare disorders.

Frontiers in pharmacology·2022
Same author

Sante publique (Vandoeuvre-les-Nancy, France)·2022
Same author

Assessing the Quality of Direct-to-Consumer Teleconsultation Services in Canada.

Studies in health technology and informatics·2022
Same journal

Parental and public views on genomic newborn screening: a systematic review.

European journal of human genetics : EJHG·2026
Same journal

Correction: follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: data from the PRED-IdF network.

European journal of human genetics : EJHG·2026
Same journal

Characterisation of the SMN1/2 locus using a highly specific variant caller on whole-genome sequence data from 500,000 individuals.

European journal of human genetics : EJHG·2026
Same journal

When truncation is not loss of function: neo-tail architecture as a determinant of pathogenicity in NMD-escaping frameshift variants.

European journal of human genetics : EJHG·2026
Same journal

CMIP as a novel candidate gene for neurodevelopmental and neuropsychiatric disorders.

European journal of human genetics : EJHG·2026
Same journal

Parent and professional experiences of a clinical trial of prenatal and postnatal stem cell therapy for severe osteogenesis imperfecta.

European journal of human genetics : EJHG·2026
See all related articles

European experts recommend a cautious approach to population genetic screening programs, balancing patient autonomy with professional duty. Further discussion is needed before widespread implementation of genetic testing for various conditions.

Area of Science:

  • Medical Genetics
  • Public Health Policy
  • Bioethics

Background:

  • Population genetic screening programs in Europe face evolving principles, practices, and policies.
  • There is a growing public health concern regarding the introduction of new genetic screening programs.
  • Ethical considerations and practical implementation require thorough examination before widespread adoption.

Purpose of the Study:

  • To examine professional and scientific views on population genetic screening in Europe.
  • To raise awareness among healthcare professionals and policymakers about potential genetic screening programs.
  • To identify and debate key issues surrounding genetic screening before and after birth.

Main Methods:

  • Review of existing professional guidelines, regulatory frameworks, and relevant documents on European genetic screening.
Keywords:
Genetics and Reproduction

Related Experiment Videos

  • Examination of debated questions concerning various types of genetic screening (pre- and post-natal).
  • International workshop with 51 experts from 15 European countries to discuss arguments for and against screening programs.

    • Main Results:

    • Screening for conditions like cystic fibrosis, Duchenne muscular dystrophy, and cancer susceptibility was discussed.
    • Key issues including informed consent, family aspects, commercialization, and program monitoring were examined.
    • Experts favored a 'proceed with caution' approach, with patient organizations advocating for expansion and policymakers showing reluctance due to ethical concerns.

    Conclusions:

    • A balanced approach is crucial, maintaining both professional duty of care and personal autonomy in genetic screening.
    • Policy-makers' concerns regarding abortion and eugenics need careful consideration but should not impede progress.
    • Further dialogue is essential to navigate the complexities of implementing population genetic screening programs responsibly.